★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Johnson & Johnson vs Zimmer Biomet Holdings, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Johnson & Johnson

JNJ · New York Stock Exchange

Market cap (USD)$651.3B
Gross margin (TTM)70.5%
Operating margin (TTM)26.8%
Net margin (TTM)21.5%
SectorHealthcare
IndustryDrug Manufacturers - General
CountryUS
Data as of2026-08-23
Moat score
73/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.

View JNJ analysis

Zimmer Biomet Holdings, Inc.

ZBH · New York Stock Exchange

Market cap (USD)$19.5B
Gross margin (TTM)69.9%
Operating margin (TTM)15.7%
Net margin (TTM)9.5%
SectorHealthcare
IndustryMedical - Devices
CountryUS
Data as of2026-08-23
Moat score
52/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Zimmer Biomet Holdings, Inc.'s moat claims, evidence, and risks.

View ZBH analysis

Comparison highlights

  • Moat score gap: Johnson & Johnson leads (73 / 100 vs 52 / 100 for Zimmer Biomet Holdings, Inc.).
  • Segment focus: Johnson & Johnson has 2 segments (64.7% in Innovative Medicine); Zimmer Biomet Holdings, Inc. has 4 segments (38.1% in Knees).
  • Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Weak.
  • Moat breadth: Johnson & Johnson has 3 moat types across 2 domains; Zimmer Biomet Holdings, Inc. has 2 across 2.

Primary market context

Johnson & Johnson

Innovative Medicine

Market

Branded prescription pharmaceuticals (biopharma)

Geography

Global

Customer

Wholesalers, hospitals, retailers, healthcare professionals, payers

Role

Drug discovery, development, manufacturing, commercialization

Revenue share

64.7%

Zimmer Biomet Holdings, Inc.

Knees

Market

Knee reconstruction implants (primary, partial, revision) plus associated instruments and orthopedic robotics/navigation

Geography

Global

Customer

Hospitals and ambulatory surgery centers

Role

OEM manufacturer

Revenue share

38.1%

Side-by-side metrics

Johnson & Johnson
Zimmer Biomet Holdings, Inc.
Ticker / Exchange
JNJ - New York Stock Exchange
ZBH - New York Stock Exchange
Market cap (USD)
$651.3B
$19.5B
Gross margin (TTM)
70.5%
69.9%
Operating margin (TTM)
26.8%
15.7%
Net margin (TTM)
21.5%
9.5%
Sector
Healthcare
Healthcare
Industry
Drug Manufacturers - General
Medical - Devices
HQ country
US
US
Primary segment
Innovative Medicine
Knees
Market structure
Competitive
Oligopoly
Market share
n/a
30.1% (reported)
HHI estimate
n/a
n/a
Pricing power
Moderate
Weak
Moat score
73 / 100
52 / 100
Moat domains
Legal, Demand
Demand, Supply
Last update
2026-08-23
2026-08-23

Moat coverage

Shared moat types

No overlap yet.

Johnson & Johnson strengths

IP Choke PointTraining Org Change CostsBrand Trust

Zimmer Biomet Holdings, Inc. strengths

Design In QualificationService Field Network

Segment mix

Johnson & Johnson segments

Full profile >

Innovative Medicine

Competitive

64.7%

MedTech

Oligopoly

35.3%

Zimmer Biomet Holdings, Inc. segments

Full profile >

Knees

Oligopoly

38.1%

Hips

Oligopoly

25.8%

S.E.T. (Sports Medicine, Extremities, Trauma, CMFT)

Competitive

26.9%

Technology & Data, Bone Cement and Surgical

Oligopoly

9.2%

Act on this comparison

Turn a two-stock debate into a systemSee the systematic rankings that surface stocks like JNJ and ZBH, with backtests and current holdings.

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.